银屑病关节炎治疗惰性前瞻性调查(OPTI'PsA)
2021年1月至3月通过电子邮件联系825名法国风湿科医生,邀请填写含7个临床情景的在线问卷,其中5个情景需优化治疗、2个对照情景无需改变治疗。101名医生完成调查,47%在至少一个需优化治疗的情景中表现出治疗惰性;寡关节炎和附着点炎情景惰性最高(20%和19%)。作者认为银屑病关节炎治疗惰性率与其他慢性病类似,需进一步研究确定原因。
要点
- 47%的受访风湿科医生在至少一个需优化治疗的情景中表现出治疗惰性。
- 寡关节炎和附着点炎情景治疗惰性最高,分别为20%和19%的医生未改变治疗。
- 多关节炎复发、肿瘤病史和心血管风险情景治疗惰性较低,分别为11%、8%和6%。
核心结论
- 银屑病关节炎中观察到的治疗惰性率与其他慢性病(如糖尿病、高血压、痛风或多发性硬化)已发表数据相似。
- 本研究首次显示银屑病关节炎中存在明显的临床惰性,需进一步研究以确定这种惰性背后的原因。
研究设计与样本
- 前瞻性调查,2021年1月至3月通过电子邮件联系825名法国风湿科医生,邀请完成在线问卷。
- 问卷包含7个临床情景:5个需优化治疗(寡关节炎、附着点炎、多关节炎、肿瘤病史、心血管风险),2个对照情景无需改变治疗(远端指间关节炎、非典型中轴受累)。
- 101名风湿科医生完成OPTI'PsA调查。
主要发现
- 近半数受访者(47%)在至少一个需优化治疗的5个情景中表现出治疗惰性。
- 寡关节炎情景中20%的受访者未修改治疗,附着点炎情景中19%未修改治疗。
- 多关节炎复发情景中11%的受访者选择不改变当前治疗,肿瘤病史情景为8%,心血管风险情景为6%。
局限性
- 需进一步研究以确定这种惰性背后的原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Clinical inertia, or therapeutic inertia (TI), is the medical behaviour of not initiating or intensifying treatment when recommended by clinical recommendations. To our knowledge, our survey is the first to assess TI around psoriatic arthritis (PsA). METHODS: Eight hundred and twenty-five French rheumatologists were contacted via email between January and March 2021 and invited to complete an online questionnaire consisting of seven clinical vignettes: five cases ('oligoarthritis', 'enthesitis', 'polyarthritis', 'neoplastic history', 'cardiovascular risk') requiring treatment OPTImization, and two 'control' cases (distal interphalangeal arthritis, atypical axial involvement) not requiring any change of treatment-according to the most recent PsA recommendations. Rheumatologists were also questioned about their routine practice, continuing medical education and perception of PsA. RESULTS: One hundred and one rheumatologists completed this OPTI'PsA survey. Almost half the respondents (47%) demonstrated TI on at least one of the five vignettes that warranted treatment optimization. The complex profiles inducing the most TI were 'oligoarthritis' and 'enthesitis' with 20% and 19% of respondents not modifying treatment, respectively. Conversely, clinical profiles for which there was the least uncertainty ('polyarthritis in relapse', 'neoplastic history' and 'cardiovascular risk') generated less TI with 11%, 8% and 6% of respondents, respectively, choosing not to change the current treatment. CONCLUSION: The rate of TI we observed for PsA is similar to published data for other chronic diseases such as diabetes, hypertension, gout or multiple sclerosis. Our study is the first to show marked clinical inertia in PsA, and further research is warranted to ascertain the reasons behind this inertia.
引用
- Lioté F, Constantin A, Dahan É, et al. A prospective survey on therapeutic inertia in psoriatic arthritis (OPTI'PsA). Rheumatology (Oxford). 2024. PMID: 37261843. doi:10.1093/rheumatology/kead262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。